Physician

Bhargav Mudda, M.D.

According to 2025 Medicare claims, Bhargav Mudda, M.D. (NPI: 1346501699) practices interventional pain management (ipm) in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is DR KAMRAN PARSA INC (NPI: 1780066373; TIN: 474144142) and primary practice location at 93551-1432. Mudda is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Mudda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 155 traditional Medicare patients, billed 1,101 HCPCS/CPT codes, and received $163,720 in Medicare payments. The top billing code was 64635 (Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint). Part D data shows 2,620 prescription claims across 428 beneficiaries totaling $65,779 in drug costs, led by Celecoxib (Celecoxib). DME data shows 14 claims. Open Payments data shows 32 records totaling $1,603. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $11,481 to $65,779. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	301	3,025	$180,625
2019	327	3,725	$259,076
2020	272	3,214	$227,646
2021	270	2,660	$234,739
2022	150	1,062	$165,253
2023	176	1,130	$173,014
2024	155	1,101	$163,720

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	49	262	$11,481
2016	34	146	$3,770
2017	180	843	$35,873
2018	312	2,182	$80,040
2019	262	2,204	$85,455
2020	262	2,031	$67,514
2021	227	1,430	$42,230
2022	279	1,175	$55,690
2023	431	2,479	$84,995
2024	428	2,620	$65,779

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$813
2024	N/R	14	$855

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64635	Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint	36	61	$394
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	39	47	$233
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	46	69	$102
99442	Telephone medical discussion with physician, 11-20 minutes	104	332	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	48	62	$68

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Celecoxib	Celecoxib	191	6,000	$12,788
Lidocaine	Lidocaine	229	6,025	$9,168
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	122	3,456	$8,274
Nucynta	Tapentadol Hcl	12	360	$8,261
Methocarbamol	Methocarbamol	402	12,140	$4,660

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	14	$855

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$1,603	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bhargav Mudda, M.D.?

Tedicare shows public-source Medicare data for Bhargav Mudda, M.D. (NPI 1346501699), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bhargav Mudda, M.D. have ACO affiliation data?

Bhargav Mudda, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Bhargav Mudda, M.D.?

Bhargav Mudda, M.D. is linked to DR KAMRAN PARSA INC (billing NPI 1780066373) in the available physician profile data.

Does Bhargav Mudda, M.D. have Open Payments data?

Bhargav Mudda, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.